What to expect 6 min readUpdated September 1, 2026
How Long Does Stem Cell Therapy Last?
PWritten by: Phil KimMedically reviewed by: Dr. Robert Aki, DPMLast medically reviewed: September 4, 2026
Stem cell therapy does not have an expiration date. How long results last depends on your condition, the health and loading of the treated tissue, your age, your activity level, and whether you follow the rehabilitation plan. This guide explains what a realistic timeline looks like and what you can do to help results last as long as possible.
5
clinical providers on the team
22+ years
combined clinical experience
12+
treatments & services offered
There is no one-size-fits-all answer
How long a stem cell treatment lasts varies from person to person, because it depends on what is being treated and how well that tissue can respond. A provider can give you an honest range based on your imaging, your history, and the condition being addressed, but nobody can responsibly promise a specific number of months or years.
What a realistic timeline looks like
Improvement, when it comes, usually builds gradually. Many patients report the first noticeable change in the weeks after treatment, with the fuller effect unfolding over several months as the tissue remodels. From there, how long the benefit holds depends mostly on how you load the joint and what you do next.
Weeks one to six: keeping the treated area rested while easing back into everyday movement
Months one to three: rebuilding strength with guided physical therapy and progressive activity
Months three and beyond:a maintenance phase you protect with strength training, weight management, and joint-friendly habits
What makes results last longer
The tissue does not heal in isolation. A stronger muscle and a healthier body weight take load off the treated joint, and consistent rehabilitation builds the support system around the repair. Avoiding the same repetitive strain that led to the injury, and coming back for scheduled follow-up care, are the choices most likely to extend results.
Can you repeat the treatment?
Some patients revisit their provider months or years later for a follow-up treatment, especially for progressive conditions like osteoarthritis. Whether a second round makes sense depends on how you responded the first time, how much the condition has advanced, and what your provider sees on follow-up imaging and exam. This is exactly the kind of question a consultation can answer honestly.
Frequently asked questions
How quickly will I notice results? Most patients who improve begin to notice a change gradually, over weeks to months, rather than days. Timelines vary by condition and by person.
Does insurance cover regenerative treatments? Most regenerative treatments are not covered by health insurance. Confirm costs and coverage with the clinic before you book.
Will I need more than one treatment? Often one carefully planned treatment with a rehabilitation program is the starting point, though some patients do benefit from follow-up treatment later. Your provider will advise based on your case.
At Aloha Stem Cell, we prefer honest ranges over rose-colored promises. Call our team at (808) 593-2525 to talk through the long-term picture for your specific situation.
Want to talk through your own situation?
Our team is happy to listen to your story, answer your questions, and help you decide
whether a consultation makes sense. There is no pressure and no obligation.
The FDA now lists Regenecyte, a cord blood stem cell product, among approved cellular therapies. It is a real milestone for blood stem cell transplant patients, and it is not a treatment for joint pain. Here is what the approval is, what it is not, and why it matters when you read stem cell news.
In September 2026 the FDA granted Fast Track status to an experimental cell therapy for ALS, and in August researchers presented new Phase 1/2 data on a stem cell therapy for Parkinson's. Both are real advances and both remain investigational. Here is the honest read.
A stem cell-derived islet therapy restored insulin production in early trials, with 10 of 12 patients insulin-independent at one year. Here is what the 2025-2026 results show, what the FDA has and has not done, and what it means for people with diabetes.